Amcor Pharma Private Limited
About Amcor Pharma Private Limited
Data last updated:
Amcor Pharma Private Limited is a private limited company based in Amravati, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24100MH2010PTC402588. Its GSTIN is 27AALCA1068N1ZA (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.61 Lakh. It is led by directors Krutika Shitalkumar Lodha and Shitalkumar Sumatilal Lodha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Amravati, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹71.03 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹2.83 Lakh (net margin 4%) and EBITDA of ₹3.98 Lakh (EBITDA margin 5.6%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRashi Apartment Flat No. 303, In Front Of Brhaman Sabha Gruh Rajapeth, Amravati, Maharashtra, India – 444601
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Amcor Pharma Private Limited
The main business activity of Amcor Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Amcor Pharma Private Limited FY 2025 filings available
Amcor Pharma Private Limited reported revenue of ₹71.03 Lakh (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Amcor Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 11% fall in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Amcor Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.98 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.83 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Amcor Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Amcor Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Amcor Pharma Private Limited
Amcor Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thrive Therapeutic Private Limited | ₹71.9 Lakh (FY 2025) | •••• | •••• | -82.0% | •••• | Thane, Maharashtra, India |
| Lucon Pharma and Research Private Limited | ₹71.82 Lakh (FY 2024) | •••• | •••• | 476.0% | •••• | Roorkee, Uttarakhand, India |
| Xylia Pharmaceuticals Private Limited | ₹71.26 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Kozhikode, Kerala, India |
| Sentonssa Wellness Private Limited | ₹71.16 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Siddhpur, Gujarat, India |
| French Biologicals Private Limited | ₹71.09 Lakh (FY 2024) | •••• | •••• | 9.0% | •••• | Hyderabad, Telangana, India |
| Amcor Pharma Private Limited this company | ₹71.03 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Amravati, Maharashtra, India |
| Nevuron India Private Limited | ₹70.92 Lakh (FY 2025) | •••• | •••• | 20.0% | •••• | New Delhi, Delhi, India |
| Kesar Drugs Private Limited | ₹70.91 Lakh (FY 2025) | •••• | •••• | 4984.0% | •••• | Panchkula, Haryana, India |
| Sequent Penems Private Limited | ₹70.86 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Arb Remedies Private Limited | ₹70.84 Lakh (FY 2025) | •••• | •••• | 81.0% | •••• | Pune, Maharashtra, India |
| Vizag Pharmaceuticals Private Limited | ₹70.81 Lakh (FY 2016) | •••• | •••• | -52.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Amcor Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Amcor Pharma Private Limited
Amcor Pharma Private Limited is audited by ANKIT ASAWA & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANKIT ASAWA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Amcor Pharma Private Limited
Amcor Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krutika Shitalkumar Lodha | Director | 01 Nov 2012 | 13 Years 11 Months | Current |
| Shitalkumar Sumatilal Lodha Also directs: Rocma Ceutics (OPC) Private Limited | Director | 23 Jan 2010 | 16 Years 8 Months | Current |
Ownership and Shareholding of Amcor Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Amcor Pharma Private Limited
Amcor Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Amcor Pharma Private Limited
Employment history and EPFO contributions of people linked to Amcor Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Amcor Pharma Private Limited
Amcor Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100MH2010PTC402588, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100MH2010PTC402588 | Current |
| U24100MH2010PTC199260 | Previous |
| U24100PN2010PTC151540 | Previous |
Recent Activity on Amcor Pharma Private Limited
Amcor Pharma Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Girish Nandkishor Gangan ceased to be Director on 02 Nov 2012.
Credit Ratings, Litigation & Regulatory Alerts for Amcor Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Amcor Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Amcor Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Amcor Pharma Private Limited
Amcor Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCA1068N1ZA | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Amcor Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amcor Pharma Private Limited
Amcor Pharma is an active private limited company based in Amravati, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 January 2010 (16+ years old) and is registered under CIN U24100MH2010PTC402588.
Amcor Pharma reported revenue of ₹71.03 Lakh for FY 2025 (down 11% YoY).
Amcor Pharma has 2 current directors:
- Krutika Shitalkumar Lodha - Director
- Shitalkumar Sumatilal Lodha - Director
Amcor Pharma reported a net profit of ₹2.83 Lakh (net margin 4%) and EBITDA of ₹3.98 Lakh (EBITDA margin 5.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Amcor Pharma is -14% over three years and -3% over five years. In the latest year (FY 2025) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Amcor Pharma is 27AALCA1068N1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Amcor Pharma is U24100MH2010PTC402588. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amcor Pharma was incorporated on 23 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Nagpur.
The peers of Amcor Pharma by revenue are Thrive Therapeutic Private Limited, Lucon Pharma and Research Private Limited, Xylia Pharmaceuticals Private Limited, Sentonssa Wellness Private Limited, French Biologicals Private Limited and 5 more, all in the Pharma industry (Formulations).
Girish Nandkishor Gangan ceased to be Director on 02 Nov 2012. Gopal Pundlik Londe ceased to be Director on 02 Nov 2012. Krutika Shitalkumar Lodha was appointed as Director on 01 Nov 2012. Amcor Pharma has 4 board changes on record in total.
The registered office of Amcor Pharma is at Rashi Apartment Flat No. 303, In Front Of Brhaman Sabha Gruh Rajapeth, Amravati, Maharashtra, India – 444601.